Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Amedisys Inc (AMED)
NASDAQ:AMED
Holding AMED?
Track your performance easily
AMED Stock Chart & Stats
Day’s Range― - ―
52-Week Range$82.15 - $98.95
Previous CloseN/A
Volume84.60K
Average Volume (3M)522.77K
Market Cap
$3.04B
Enterprise Value$3.47B
Total Cash (Recent Filing)$30.20M
Total Debt (Recent Filing)$87.81M
Price to Earnings (P/E)37.0
Beta0.35
Next Earnings
Feb 19, 2025EPS Estimate
1.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.51
Shares Outstanding32,754,463
10 Day Avg. Volume352,963
30 Day Avg. Volume522,772
Standard Deviation0.11
R-Squared0.13
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.31
Price to Cash Flow (P/CF)7.20
P/FCF Ratio7.30
Enterprise Value/Market Cap1.14
Enterprise Value/Revenue1.21
Enterprise Value/Gross Profit3.50
Enterprise Value/Ebitda13.94
Forecast
1Y Price Target
$100.75Price Target Upside8.79% Upside
Rating ConsensusHold
Number of Analyst Covering5
Amedisys News
Bulls Say, Bears Say
Bulls Say
Business GrowthThe hospice segment showed growth with revenue of $207.9 million, representing a 3.8% increase, and EBITDA of $50.5 million, marking a 6% rise year-to-year.
Merger AgreementThe extension of the merger agreement between AMED and UNH includes amendments beneficial to Amedisys, such as a larger regulatory break fee and increased revenue-related aspects.
Merger CompletionCertain closing conditions relating to government approvals are no longer conditions to the consummation of the merger, indicating a smoother path to completion.
Bears Say
Earnings PerformanceThe 3Q24 results came in below consensus estimates and the model.
Financial PerformanceThe adjusted EBITDA of $58.1m was below consensus and the model estimates.
Merger UncertaintyShares of Amedisys are likely to trade sideways due to the extended timeline for the merger agreement with UNH.
---
Ownership Overview
2.19% Insiders
24.06% Mutual Funds
0.02% Other Institutional Investors
46.57% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AMED FAQ
What was Amedisys Inc’s price range in the past 12 months?
Amedisys Inc lowest stock price was $82.15 and its highest was $98.95 in the past 12 months.
What is Amedisys Inc’s market cap?
Amedisys Inc’s market cap is $3.04B.
When is Amedisys Inc’s upcoming earnings report date?
Amedisys Inc’s upcoming earnings report date is Feb 19, 2025 which is in 20 days.
How were Amedisys Inc’s earnings last quarter?
Amedisys Inc released its earnings results on Nov 06, 2024. The company reported $1 earnings per share for the quarter, missing the consensus estimate of $1.193 by -$0.193.
Is Amedisys Inc overvalued?
According to Wall Street analysts Amedisys Inc’s price is currently Undervalued.
Does Amedisys Inc pay dividends?
Amedisys Inc does not currently pay dividends.
What is Amedisys Inc’s EPS estimate?
Amedisys Inc’s EPS estimate is 1.06.
How many shares outstanding does Amedisys Inc have?
Amedisys Inc has 32,754,463 shares outstanding.
What happened to Amedisys Inc’s price movement after its last earnings report?
Amedisys Inc reported an EPS of $1 in its last earnings report, missing expectations of $1.193. Following the earnings report the stock price went down -0.931%.
Which hedge fund is a major shareholder of Amedisys Inc?
Currently, no hedge funds are holding shares in AMED
---
Amedisys Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$100.75 (8.79% Upside)
$100.75 (8.79% Upside)
Blogger Sentiment
Neutral
AMED Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 238.3K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-2.26%
12-Months-Change
Fundamentals
Return on Equity
11.11%
Trailing 12-Months
Asset Growth
5.51%
Trailing 12-Months
Company Description
Amedisys Inc
Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, and Personal Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The company was founded by William F. Borne in 1982 and is headquartered in Baton Rouge, LA.
---
AMED Stock 12 Month Forecast
Average Price Target
$100.75
▲(8.79% Upside)
Technical Analysis
AMN Healthcare Services
―
Chemed
―
Healthcare Services
―
Encompass Health
―
The Ensign Group
―
Best Analysts Covering AMED
1 Year
Unknown AnalystRBC Capital
Not Ranked
1 Year Success Rate
0/0 ratings generated profit
1 Year Average Return
0.00%
reiterated a buy rating last month
Copying Unknown Analyst's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
---